Discuss This Drug

NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN

CHEBI:CHEBI_748909

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
route
INTRAMUSCULAR
dosage_form
INJECTION, SUSPENSION
product_type
VACCINE
marketing_category
BLA
marketing_start_date
20161201
package_marketing_start_date
20161201
active_ingredient_strength
25 ug/.5mL
labeler_name
GlaxoSmithKline Biologicals SA
generic_name
NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN
brand_name
Bexsero
brand_name_base
Bexsero
product_ndc
58160-976
application_number
BLA125546
spl_id
26d85d01-2300-4aba-b802-f9a44e0c3407
active_ingredient_name
NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN
package_ndc
58160-976-20
package_description
10 SYRINGE in 1 CARTON (58160-976-20) / .5 mL in 1 SYRINGE (58160-976-02)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class